SSTR2 and type 2 diabetes mellitus: Nonetheless while the C-peptide response in the T2D group remained, with ZT-01 treatment the HFF-ZT-01 rats had higher mean c-peptide levels with SSTR2 antagonist administration starting at t = 30 min (5.3 ± 0.7 vs. 9.2 ± 2.2 ng/mL) and at the t = 240 min time point (3.7 ± 0.7 vs. 6.1 ± 0.8 ng/mL), but the difference was not statistically significant (p = 0.06).